219 related articles for article (PubMed ID: 26176882)
1. Incorporation of Naked Peptide Nucleic Acids into Liposomes Leads to Fast and Efficient Delivery.
Avitabile C; Accardo A; Ringhieri P; Morelli G; Saviano M; Montagner G; Fabbri E; Gallerani E; Gambari R; Romanelli A
Bioconjug Chem; 2015 Aug; 26(8):1533-41. PubMed ID: 26176882
[TBL] [Abstract][Full Text] [Related]
2. The influence of liposomal formulation on the incorporation and retention of PNA oligomers.
Ringhieri P; Avitabile C; Saviano M; Morelli G; Romanelli A; Accardo A
Colloids Surf B Biointerfaces; 2016 Sep; 145():462-469. PubMed ID: 27236097
[TBL] [Abstract][Full Text] [Related]
3. Cellular delivery of peptide nucleic acid by cell-penetrating peptides.
Kilk K; Langel U
Methods Mol Biol; 2005; 298():131-41. PubMed ID: 16044544
[TBL] [Abstract][Full Text] [Related]
4. Liposomes as carriers for DNA-PNA hybrids.
Nastruzzi C; Cortesi R; Esposito E; Gambari R; Borgatti M; Bianchi N; Feriotto G; Mischiati C
J Control Release; 2000 Aug; 68(2):237-49. PubMed ID: 10925132
[TBL] [Abstract][Full Text] [Related]
5. PNA-based antisense oligonucleotides for micrornas inhibition in the absence of a transfection reagent.
Oh SY; Ju Y; Kim S; Park H
Oligonucleotides; 2010 Oct; 20(5):225-30. PubMed ID: 20946011
[TBL] [Abstract][Full Text] [Related]
6. Cellular delivery of polyheteroaromate-peptide nucleic acid conjugates mediated by cationic lipids.
Shiraishi T; Bendifallah N; Nielsen PE
Bioconjug Chem; 2006; 17(1):189-94. PubMed ID: 16417268
[TBL] [Abstract][Full Text] [Related]
7. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates.
Fabani MM; Gait MJ
RNA; 2008 Feb; 14(2):336-46. PubMed ID: 18073344
[TBL] [Abstract][Full Text] [Related]
8. Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors.
Borgatti M; Breda L; Cortesi R; Nastruzzi C; Romanelli A; Saviano M; Bianchi N; Mischiati C; Pedone C; Gambari R
Biochem Pharmacol; 2002 Aug; 64(4):609-16. PubMed ID: 12167479
[TBL] [Abstract][Full Text] [Related]
9. Peptide nucleic acids as therapeutic agents.
Nielsen PE
Curr Opin Struct Biol; 1999 Jun; 9(3):353-7. PubMed ID: 10361091
[TBL] [Abstract][Full Text] [Related]
10. Subnanomolar antisense activity of phosphonate-peptide nucleic acid (PNA) conjugates delivered by cationic lipids to HeLa cells.
Shiraishi T; Hamzavi R; Nielsen PE
Nucleic Acids Res; 2008 Aug; 36(13):4424-32. PubMed ID: 18596083
[TBL] [Abstract][Full Text] [Related]
11. Intracellular uptake and inhibition of gene expression by PNAs and PNA-peptide conjugates.
Kaihatsu K; Huffman KE; Corey DR
Biochemistry; 2004 Nov; 43(45):14340-7. PubMed ID: 15533038
[TBL] [Abstract][Full Text] [Related]
12. Delivery of Peptide Nucleic Acids Using an Argininocalix[4]arene as Vector.
Finotti A; Gasparello J; Casnati A; Corradini R; Gambari R; Sansone F
Methods Mol Biol; 2021; 2211():123-143. PubMed ID: 33336275
[TBL] [Abstract][Full Text] [Related]
13. Peptide nucleic acids targeting miR-221 modulate p27Kip1 expression in breast cancer MDA-MB-231 cells.
Brognara E; Fabbri E; Aimi F; Manicardi A; Bianchi N; Finotti A; Breveglieri G; Borgatti M; Corradini R; Marchelli R; Gambari R
Int J Oncol; 2012 Dec; 41(6):2119-27. PubMed ID: 22992757
[TBL] [Abstract][Full Text] [Related]
14. Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.
Torres AG; Threlfall RN; Gait MJ
Artif DNA PNA XNA; 2011; 2(3):71-8. PubMed ID: 22567190
[TBL] [Abstract][Full Text] [Related]
15. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
Resina S; Abes S; Turner JJ; Prevot P; Travo A; Clair P; Gait MJ; Thierry AR; Lebleu B
Int J Pharm; 2007 Nov; 344(1-2):96-102. PubMed ID: 17600642
[TBL] [Abstract][Full Text] [Related]
16. Efficient and isoform-selective inhibition of cellular gene expression by peptide nucleic acids.
Liu Y; Braasch DA; Nulf CJ; Corey DR
Biochemistry; 2004 Feb; 43(7):1921-7. PubMed ID: 14967032
[TBL] [Abstract][Full Text] [Related]
17. Molecular methods for validation of the biological activity of peptide nucleic acids targeting microRNAs.
Brognara E; Fabbri E; Bianchi N; Finotti A; Corradini R; Gambari R
Methods Mol Biol; 2014; 1095():165-76. PubMed ID: 24166312
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the biological activity of microRNA-210 with peptide nucleic acids (PNAs).
Fabbri E; Manicardi A; Tedeschi T; Sforza S; Bianchi N; Brognara E; Finotti A; Breveglieri G; Borgatti M; Corradini R; Marchelli R; Gambari R
ChemMedChem; 2011 Dec; 6(12):2192-202. PubMed ID: 22012891
[TBL] [Abstract][Full Text] [Related]
19. Cell number and transfection volume dependent peptide nucleic acid antisense activity by cationic delivery methods.
Llovera L; Berthold P; Nielsen PE; Shiraishi T
Artif DNA PNA XNA; 2012; 3(1):22-7. PubMed ID: 22679530
[TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted Delivery of Anti-microRNA for Cancer Therapy: pHLIP is Key.
Wagner E
Angew Chem Int Ed Engl; 2015 May; 54(20):5824-6. PubMed ID: 25892205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
